Figure 1From: High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study The median PFS time was 10 months, and 1- year PFS rate was 37.0%. Back to article page